Stray Kids’ I.N has once again demonstrated the power of positive influence by donating 100 million KRW (approximately 75,000 USD) to help children battling cancer.

According to JYP Entertainment, I.N made a generous donation to Samsung Medical Center in Gangnam, Seoul, on February 8. The contribution was made in celebration of his 24th birthday, reflecting his commitment to giving back to the community.

The donated funds will be allocated to the medical expenses of pediatric cancer patients, specifically those from financially disadvantaged backgrounds who are currently receiving treatment at the hospital. Through this initiative, I.N aims to provide support for young patients struggling with serious health conditions.

“I sincerely hope that children fighting cancer can regain their health and continue to grow and dream,” I.N shared. “I’m grateful to be able to give back the love I have received from my fans.”

Since his debut, I.N has been an active advocate for charitable causes. In 2023, he was recognized as the youngest-ever member of the Green Noble Club, an elite donor group under ChildFund Korea, which acknowledges individuals who contribute significant financial aid to children in need. His consistent philanthropic efforts have further solidified his reputation as an artist who leads by example.

Beyond his charitable work, I.N remains active in his music career. Stray Kids is currently embarking on their world tour dominATE, captivating audiences worldwide with their powerful performances and signature sound.

With his unwavering dedication to both music and social responsibility, I.N continues to inspire fans globally. His latest donation highlights the role that artists can play in fostering meaningful change, reinforcing Stray Kids’ influence beyond the stage.

As the group expands its global presence, I.N’s philanthropic actions serve as a reminder that success is not only measured in achievements but also in the ability to uplift others. His contributions are expected to provide crucial assistance to young patients, offering them hope for a brighter future.

Sayart / Sharon Jung, guhuijeong784@gmail.com